Bottom Line Screening
Client Login
  • Home
  • About Us
    • Background Check Value
    • Why Work With Us?
    • Testimonials
  • Background Screenings
    • Industries Served
    • Employment Screenings
    • Tenant Screening
    • Legal Resources
  • Drug & Alcohol Testing
    • Workplace Drug Testing
  • Integrity & Aptitude Assessments
    • The Science
    • The Value
  • From our Blog
    • Industry Standards
    • Human Resources
    • COVID-19
    • Why Background Screening
    • Drug Abuse
    • Drug Testing
    • Integrity Testing
    • Affiliations
    • Ban the Box
    • FCRA Compliance
    • Why Background Screening

ODAPC-Marijuana and CBD in safety sensitive positions

Posted on February 18, 2020 by Sheri Lash

The Agricultural Improvement Act of 2018, Pub. L. 115-334, (Farm Bill) removed hemp from the definition of marijuana under the Controlled Substances Act. Under the Farm Bill, hemp-derived products containing a concentration of up to 0.3% tetrahydrocannabinol (THC) are not controlled substances. THC is the primary psychoactive component of marijuana. Any product, including “Cannabidiol” (CBD) products, with a concentration of more than 0.3% THC remains classified as marijuana, a Schedule I drug under the Controlled Substances Act.

It is important for all employers and safety-sensitive employees to know:

1. The Department of Transportation requires testing for marijuana and not CBD.

2. The labeling of many CBD products may be misleading because the products could contain higher levels of THC than what the product label states. The Food and Drug Administration (FDA) does not currently certify the levels of THC in CBD products, so there is no federal oversight to ensure that the labels are accurate. The FDA has cautioned the public that: “Consumers should beware purchasing and using any [CBD] products.” The FDA has stated: “It is currently illegal to market CBD by adding it to a food or labeling it as a dietary supplement.” Also, the FDA has issued several warning letters to companies because their products contained more CBD than indicated on the product label.

3. The Department of Transportation’s Drug and Alcohol Testing Regulation, Part 40, does not authorize the use of Schedule I drugs, including marijuana, for any reason. Furthermore, CBD use is not a legitimate medical explanation for a laboratory-confirmed marijuana positive result. Therefore, Medical Review Officers will verify a drug test confirmed at the appropriate cutoffs as positive, even if an employee claims they only used a CBD product.

It remains unacceptable for any safety-sensitive employee subject to the Department of Transportation’s drug testing regulations to use marijuana. Since the use of CBD products could lead to a positive drug test result, the Department of Transportation-regulated safety-sensitive employees should exercise caution when considering whether to use CBD products.

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook

Like this:

Like Loading...

Related

Posted in Industry Standards |
« Opioid Epidemic
Candidates are manipulating their employment documents »

Contact Us

Bottom Line Screening
South Haven, Michigan 49090

Office: 269-214-0697
info@BottomLineScreening.com

Hours of Operation: Monday - Friday 9am - 5pm

Blog Categories

  • COVID-19
  • Drug Abuse
  • Drug Testing
  • FCRA Compliance
  • Human Resources
  • Industry Standards
  • Integrity Testing
  • Tenant Screenings
  • Uncategorized
  • Why Background Screening

Contact Us

Bottom Line Screening
South Haven, Michigan 49090

Office: 269-214-0697
info@BottomLineScreening.com

Hours of Operation: Monday - Friday 9am - 5pm

  • Privacy Policy
© Copyright 2024. Bottom Line Screening. All Rights Reserved.

© Copyright 2026. Bottom Line Screening. All Rights Reserved.

Developed & hosted by Sensible Websites

%d